Lilly(Eli) & Co

NYSE:LLY   3:59:58 PM EDT
330.01
-4.37 (-1.31%)
Products, Expansion

Lacerta And Prevail, A Wholly Owned Subsidiary Of Lilly, Sign Agreement To Develop Novel AAV Capsids For CNS Disorders

Published: 08/23/2022 08:40 GMT
Lilly(Eli) & Co (LLY) - Lacerta and Prevail, a Wholly Owned Subsidiary of Lilly, Sign Agreement to Develop Novel Aav Capsids for Cns Disorders.